A deep learning approach to identify gene targets of a therapeutic for human splicing disorders

D Gao, E Morini, M Salani, AJ Krauson… - Nature …, 2021 - nature.com
Pre-mRNA splicing is a key controller of human gene expression. Disturbances in splicing
due to mutation lead to dysregulated protein expression and contribute to a substantial …

Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations

E Pros, C Gómez, T Martín, P Fábregas… - Human …, 2008 - Wiley Online Library
Abstract Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disorder
caused by mutations in the NF1 gene. In this paper we report our experience using the …

Aberrant splicing, hyaluronan synthases and intracellular hyaluronan as drivers of oncogenesis and potential drug targets

S Adamia, PM Pilarski, AR Belch… - Current Cancer Drug …, 2013 - ingentaconnect.com
Current evidence suggests a significant role of aberrant splicing in the development and
maintenance of malignancy. This multistep, tightly regulated epigenetic process leads to the …

Neurofibromatosis type 1: from presentation and diagnosis to vascular and endovascular therapy

KT Delis, P Gloviczki - Perspectives in vascular surgery and …, 2006 - journals.sagepub.com
Neurofibromatosis type 1, also called von Recklinghausen's disease, is an autosomal
dominant disorder linked to chromosome 17, characterized by growth impairment of the …

Prevalence, Type, and Molecular Spectrum of NF1 Mutations in Patients with Neurofibromatosis Type 1 and Congenital Heart Disease

V Pinna, P Daniele, G Calcagni, L Mariniello… - Genes, 2019 - mdpi.com
The aim of this study was to assess the prevalence and type of congenital heart disease
(CHD) and the associated mutation spectrum in a large series of patients with …

Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1

A Assunto, U Ferrara, A De Luca, C Pivonello… - Orphanet Journal of …, 2019 - Springer
Abstract Background Neurofibromatosis type 1 (NF1) is characterized by an extreme clinical
variability both within and between families that cannot be explained solely by the nature of …

Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense‐mediated mRNA decay

G Nogales‐Gadea, JC Rubio… - Human …, 2008 - Wiley Online Library
Nearly 35% of all mutations identified in the muscle glycogen phosphorylase gene (PYGM)
in patients with McArdle disease result in premature termination codons (PTCs), particularly …

Functional analysis of splicing mutations in exon 7 of NF1gene

I Bottillo, A De Luca, A Schirinzi, V Guida… - BMC Medical …, 2007 - Springer
Background Neurofibromatosis type 1 is one of the most common autosomal dominant
disorders, affecting about 1: 3,500 individuals. NF1 exon 7 displays weakly defined exon …

Allele-specific expression of APC in adenomatous polyposis families

E Castellsagué, S González, E Guinó, KN Stevens… - Gastroenterology, 2010 - Elsevier
BACKGROUND & AIMS: Germline mutations in the APC gene cause of most cases of
familial adenomatous polyposis (FAP) and a lesser proportion of attenuated FAP (AFAP) …

A de novo SOX10 mutation causing severe type 4 Waardenburg syndrome without Hirschsprung disease

Y Sznajer, C Coldéa, F Meire, I Delpierre… - American Journal of …, 2008 - Wiley Online Library
Type 4 Waardenburg syndrome represents a well define entity caused by neural crest
derivatives anomalies (melanocytes, intrinsic ganglion cells, central, autonomous and …